Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Editas Medicine, Inc. | CEO, Director | Common Stock | 314K | $1.07M | $3.42 | Sep 4, 2024 | Direct |
Editas Medicine, Inc. | CEO, Director | Stock Option (right to buy) | 392K | Mar 2, 2024 | Direct | ||
Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40K | May 26, 2022 | Direct | ||
Unity Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EDIT | Editas Medicine, Inc. | Sep 4, 2024 | 1 | -$5.33K | 4 | Sep 6, 2024 | CEO, Director |
UBX | Unity Biotechnology, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
EDIT | Editas Medicine, Inc. | Jun 4, 2024 | 1 | -$67K | 4 | Jun 6, 2024 | CEO, Director |
EDIT | Editas Medicine, Inc. | Mar 2, 2024 | 5 | -$733K | 4 | Mar 5, 2024 | CEO, Director |
UBX | Unity Biotechnology, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
EDIT | Editas Medicine, Inc. | Jun 5, 2023 | 1 | -$61.6K | 4 | Jun 7, 2023 | CEO, Director |
EDIT | Editas Medicine, Inc. | Mar 2, 2023 | 2 | $0 | 4 | Mar 6, 2023 | CEO, Director |
UBX | Unity Biotechnology, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
EDIT | Editas Medicine, Inc. | Jun 2, 2022 | 2 | $0 | 4 | Jun 6, 2022 | CEO, Director |
EDIT | Editas Medicine, Inc. | Jun 1, 2022 | 0 | $0 | 3 | Jun 6, 2022 | CEO, Director |
APTX | Aptinyx Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
APTX | Aptinyx Inc. | Oct 19, 2021 | 1 | $0 | 4 | Oct 22, 2021 | Director |
APTX | Aptinyx Inc. | Oct 19, 2021 | 0 | $0 | 3 | Oct 22, 2021 | Director |
UBX | Unity Biotechnology, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |